These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10173118)

  • 1. Dissecting drug cost trends.
    Navarro RP
    Med Interface; 1997 Jul; 10(7):80-2. PubMed ID: 10173118
    [No Abstract]   [Full Text] [Related]  

  • 2. Current trends in pharmacy benefit management.
    Sweet B
    Am J Manag Care; 2002 Nov; Suppl():5-8. PubMed ID: 12463412
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 4. 1993 changes in drug cost for inpatient services.
    Mehl B
    Hosp Pharm; 1994 Aug; 29(8):771-3. PubMed ID: 10171916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives. Options vs. limits: drug cost strategies reconsidered.
    Cunningham R
    Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare survey offers data, trends in drug utilization, costs.
    Public Sect Contract Rep; 1999 Sep; 5(9):142-3. PubMed ID: 10621118
    [No Abstract]   [Full Text] [Related]  

  • 8. Stats & facts. Pharmaceutical utilization contributes to the rise in pharmacy costs.
    Manag Care Interface; 2000 Dec; 13(12):52-3. PubMed ID: 11147547
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug utilization still growing, though price increases moderate for common nonspecialty drugs.
    Capitation Rates Data; 2007 Aug; 12(8):94-6. PubMed ID: 17703704
    [No Abstract]   [Full Text] [Related]  

  • 10. Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes.
    Guo JJ; Jing Y; Nguyen K; Fan H; Li X; Kelton CM
    J Med Econ; 2008; 11(4):671-94. PubMed ID: 19450075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven therapeutic categories account for most drug cost increases.
    Manag Care; 2011 Dec; 20(12):69. PubMed ID: 22259880
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decomposing pharmaceutical cost growth in different types of health plans.
    Chernew ME; Smith DG; Kirking DM; Fendrick AM
    Am J Manag Care; 2001 Jul; 7(7):667-73. PubMed ID: 11464425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stretching the managed care dollar in the new millennium: the practice of detailing primary care physicians.
    Hill CD; Bunn DN; Hawkins JR
    Manag Care Q; 2002; 10(2):18-23. PubMed ID: 12148477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study examines weapons in fight to control drug costs.
    Capitation Rates Data; 2001 Apr; 6(4):39-42. PubMed ID: 11330005
    [No Abstract]   [Full Text] [Related]  

  • 16. Control your exposure for costs of injectables, biologics.
    Capitation Rates Data; 2002 Dec; 7(12):137-8. PubMed ID: 12506731
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating the pharmaceutical industry: who really benefits?
    Stano M
    Am J Manag Care; 2000 Jan; 6(1):29-31. PubMed ID: 11009744
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking inside the nation's medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001.
    Moeller JF; Miller GE; Banthin JS
    Health Aff (Millwood); 2004; 23(5):217-25. PubMed ID: 15371388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost and availability of prescription drugs--what can we do in Massachusetts?
    Carpenter NW; Kedikoglou S
    Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.